GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » Shares Outstanding (Diluted Average)

SynBiotic SE (XTER:SBX) Shares Outstanding (Diluted Average) : 4.75 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is SynBiotic SE Shares Outstanding (Diluted Average)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. SynBiotic SE's average diluted shares outstanding for the quarter that ended in Dec. 2023 was 4.75 Mil.


SynBiotic SE Shares Outstanding (Diluted Average) Historical Data

The historical data trend for SynBiotic SE's Shares Outstanding (Diluted Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynBiotic SE Shares Outstanding (Diluted Average) Chart

SynBiotic SE Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (Diluted Average)
Get a 7-Day Free Trial 0.26 1.59 3.11 4.08 4.75

SynBiotic SE Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23
Shares Outstanding (Diluted Average) Get a 7-Day Free Trial Premium Member Only 3.40 3.73 3.73 4.59 4.75

SynBiotic SE Shares Outstanding (Diluted Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


SynBiotic SE  (XTER:SBX) Shares Outstanding (Diluted Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


SynBiotic SE Shares Outstanding (Diluted Average) Related Terms

Thank you for viewing the detailed overview of SynBiotic SE's Shares Outstanding (Diluted Average) provided by GuruFocus.com. Please click on the following links to see related term pages.


SynBiotic SE Business Description

Industry
Traded in Other Exchanges
N/A
Address
Barer Strasse 7, Munich, BY, DEU, 80333
SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.
Executives
Daniel Kruse Geschäftsführender Direktor

SynBiotic SE Headlines

No Headlines